Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of February 2026
Peter Prince @Peter Prince
Platinum member since January 2017

Location: United States

Gender: Male

Asset investment style: Quantitative technical analysis

Market capitalization:

$8,284,390talents

Virtual portfolio value:

$5,308,017talents

Net overall return per annum:

20.01%

AYA current rank order:

#5

Asset investment philosophy:
Peter Prince trades U.S. stocks with the top #401 to #500 positive alpha signals.

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
VATE INNOVATE Corp. Common Stock $0.53 $4.14 76,537 +681.13% $276,299
RMBL RumbleOn Inc. Class B Common Stock $0.36 $7.95 14,872 +2,108.33% $112,878
TEAM Atlassian Corporation Class A Common Stock $28.92 $224.83 201 +677.42% $39,378
SHOP Shopify Inc. Class A Subordinate Voting Shares $56.05 $426.82 104 +661.50% $38,560
AXSM Axsome Therapeutics Inc. Common Stock $4.60 $31.75 1,267 +590.22% $34,399
LSCC Lattice Semiconductor Corporation Common Stock $6.97 $48.04 836 +589.24% $34,335
SQ Block Inc. Class A Common Stock $14.50 $99.54 402 +586.48% $34,186
FIVN Five9 Inc. Common Stock $16.31 $110.10 357 +575.05% $33,483
TRNS Transcat Inc. Common Stock $11.35 $73.00 513 +543.17% $31,626
GLOB Globant S.A. Common Shares $34.57 $215.99 168 +524.79% $30,479
Sum $665,623

Top 10 current stock portfolio positions as of February 2026Strategy

Top 20 influencers

#1 - #5 #6 - #10 #11 - #15 #15 - #20
@alin
@Chanel Holden
@Andy Yeh Alpha

Top 20 favorite stocks

#1 - #5 #6 - #10 #11 - #15 #15 - #20
$PSKY $DIS
$WBD $NFLX
$BILI
$IQ
$AAPL

Blog+More

The Chinese central bank has to circumvent offshore imports-driven inflation due to Renminbi currency misalignment.

Amy Hamilton

2019-07-07 18:36:00 Sunday ET

The Chinese central bank has to circumvent offshore imports-driven inflation due to Renminbi currency misalignment.

The Chinese central bank has to circumvent offshore imports-driven inflation due to Renminbi currency misalignment. Even though China keeps substantial fore

+See More

Ford and Baidu team up to test autonomous cars in China.

Jonah Whanau

2018-11-01 08:36:00 Thursday ET

Ford and Baidu team up to test autonomous cars in China.

Ford and Baidu team up to test autonomous cars in China. For the next few years, Ford and Baidu plan to collaborate on the car design and user acceptance te

+See More

France and Germany are the biggest beneficiaries of Sino-U.S. trade escalation.

Chanel Holden

2019-07-11 10:48:00 Thursday ET

France and Germany are the biggest beneficiaries of Sino-U.S. trade escalation.

France and Germany are the biggest beneficiaries of Sino-U.S. trade escalation, whereas, Japan, South Korea, and Taiwan suffer from the current trade stando

+See More

Federal Reserve delivers a second interest rate hike to 1.75%-2% and then expects more rate increases in late-2018.

Charlene Vos

2018-06-08 13:35:00 Friday ET

Federal Reserve delivers a second interest rate hike to 1.75%-2% and then expects more rate increases in late-2018.

The Federal Reserve delivers a second interest rate hike to 1.75%-2% and then expects subsequent rate increases in September and December 2018 to dampen inf

+See More

Central banks learn to weigh the monetary policy trade-offs between output and inflation expectations and macro-financial stress conditions.

Becky Berkman

2026-01-31 10:31:00 Saturday ET

Central banks learn to weigh the monetary policy trade-offs between output and inflation expectations and macro-financial stress conditions.

  In recent years, several central banks conduct, assess, and discuss the core lessons, rules, and challenges from their monetary policy framework r

+See More

The global market for GLP-1 weight-loss medications can grow substantially to benefit more than 1 billion people worldwide by 2030.

Monica McNeil

2025-10-31 12:26:00 Friday ET

The global market for GLP-1 weight-loss medications can grow substantially to benefit more than 1 billion people worldwide by 2030.

With respect to wider weight loss treatment and obesity treatment, the global market for GLP-1 medications now grows substantially to benefit more than 1 bi

+See More